Skip to main content

5 articles related to "Tirapazamine"

No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.

Articles

Original Research

Published on 21 Feb 2022

Biomimetic Metal-Organic Framework Nanoparticles for Synergistic Combining of SDT-Chemotherapy Induce Pyroptosis in Gastric Cancer

in Nanobiotechnology

Zhu Yu
Wenlong Cao
Chuangye Han
Zhen Wang
Yue Qiu
Jiancheng Wang
Mengda Wei
Junfu Wang
Siwen Zhang
Senfeng Liu

Frontiers in Bioengineering and Biotechnology

doi 10.3389/fbioe.2022.796820

7,665 views
56 citations

Original Research

Published on 09 Jun 2023

Application of tumor pH/hypoxia-responsive nanoparticles for combined photodynamic therapy and hypoxia-activated chemotherapy

in Biomaterials

Zhang Zhang
Jintang Feng
Tianzhu Zhang
An Gao
Chunyang Sun

Frontiers in Bioengineering and Biotechnology

doi 10.3389/fbioe.2023.1197404

4,197 views
13 citations

Original Research

Published on 03 Feb 2025

Hypoxia-driven mobilization of altruistic cancer stem cells in platinum-treated head and neck cancer

in Microbial Immunology

Lekhika Pathak
Bidisha Pal
Joyeeta Talukdar
Partha Jyoti Saikia
Sorra Sandhya
Wale Tasabehji
Hong Li
Jyotirmoy Phukan
Anjan Bhuyan
Sanjukta Patra

Frontiers in Immunology

doi 10.3389/fimmu.2024.1336882

4,331 views
2 citations

Hypothesis and Theory

Published on 27 Dec 2013

Design of Optimized Hypoxia-Activated Prodrugs Using Pharmacokinetic/Pharmacodynamic Modeling

in Pharmacology of Anti-Cancer Drugs

Annika Bettina Foehrenbacher
Timothy W. Secomb
William R. Wilson
Kevin O Hicks

Frontiers in Oncology

doi 10.3389/fonc.2013.00314

10,477 views
41 citations

Original Research

Published on 11 Aug 2017

Reductive Metabolism Influences the Toxicity and Pharmacokinetics of the Hypoxia-Targeted Benzotriazine Di-Oxide Anticancer Agent SN30000 in Mice

in Experimental Pharmacology and Drug Discovery

Yongchuan Gu
Tony T.-A. Chang
Jingli Wang
Jagdish K. Jaiswal
David Edwards
Noel J. Downes
H. D. Sarath Liyanage
Courtney R. H. Lynch
Frederik B. Pruijn
Anthony J. R. Hickey

Frontiers in Pharmacology

doi 10.3389/fphar.2017.00531

5,230 views
17 citations